FDA takes action against companies for illegally selling products claiming to treat AD
The FDA posted 12 warning letters and 5 online advisory letters issued to foreign and domestic companies that are illegally selling more than 58 products which are unapproved new drugs and/or misbranded drugs that claim to prevent, treat or cure Alzheimer’s disease. February 11, 2019
